Cardiology Plus

ORIGINAL ARTICLE
Year
: 2021  |  Volume : 6  |  Issue : 3  |  Page : 166--173

The relationship between c-reactive protein and cardiovascular events in patients with obstructive and nonobstructive coronary artery disease


Hui-Wen Zhang, Yuan-Lin Guo, Cheng-Gang Zhu, Na-Qiong Wu, Ying Gao, Qian Dong, Jing Sun, Jian-Jun Li 
 National Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Fu Wai Hospital, Beijing 100037, China

Correspondence Address:
Jian-Jun Li
National Center for Cardiovascular Disease, State Key Laboratory of Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Fu Wai Hospital, No 167 BeiLiShi Road, XiCheng District, Beijing 100037
China

Background and Objectives: Patients with nonobstructive coronary artery disease (NOCAD) have an increased risk of cardiovascular events (CVEs) compared to that in individuals with normal or near-normal coronary arteries (NNCAs) and even a similar risk to that in individuals with obstructive coronary artery disease (OCAD). However, the predictors for a worse outcome in patients with NOCAD are not fully determined. This study aimed to investigate the association of high-sensitive C-reactive protein (hs-CRP) and CVEs in patients with NOCAD. Materials and Methods: In total, 4662 patients with coronary artery angiography were enrolled and followed up for CVE. Patients were classified as having NNCA (<20% stenosis, n = 698, 15.0%), NOCAD (20%–49% stenosis, n = 639, 14.3%), and OCAD (≥50% stenosis, n = 3325, 70.7%) and then further subdivided into three groups based on their baseline hs-CRP level (<1, 1–3, and >3 mg/L). Proportional hazards models were used to assess the risk of CVEs. Results: Over an average 13403 person-year follow-up, 338 patients experienced CVEs. Patients with NOCAD and OCAD had a higher rate of CVE than those with NNCA (P < 0.05). The CVE risk was significantly higher in NOCAD (hazard ratio [HR]: 2.31, 95% confidence interval [CI]: 1.30–4.01, P = 0.004) and OCAD (HR: 3.09, 95% CI: 1.88–5.07, P < 0.001) patients than in NNCA patients. Moreover, elevated hs-CRP levels were associated with an incremental rate of CVE (P < 0.05). Conclusions: Patients with NOCAD had worse outcomes and elevated hs-CRP levels were positively associated with CVEs, which potentially helps assess risk in NOCAD patients.


How to cite this article:
Zhang HW, Guo YL, Zhu CG, Wu NQ, Gao Y, Dong Q, Sun J, Li JJ. The relationship between c-reactive protein and cardiovascular events in patients with obstructive and nonobstructive coronary artery disease.Cardiol Plus 2021;6:166-173


How to cite this URL:
Zhang HW, Guo YL, Zhu CG, Wu NQ, Gao Y, Dong Q, Sun J, Li JJ. The relationship between c-reactive protein and cardiovascular events in patients with obstructive and nonobstructive coronary artery disease. Cardiol Plus [serial online] 2021 [cited 2022 Jan 21 ];6:166-173
Available from: https://www.cardiologyplus.org/article.asp?issn=2470-7511;year=2021;volume=6;issue=3;spage=166;epage=173;aulast=Zhang;type=0